Risk Assessment, Part 1

Integration of Epstein-Barr virus into the host genome: a potential risk factor for the development of malignant lymphoma.

A. Staratschek-Jox MD , J. Bullerdiek PhD , J. Wolf MD

Late genetic effects of cancer therapy in cured ALL (acute lymphoblastic leukemia) and non-Hodgkins lymphoma patients as detected by DNA rearrangements

ML Camparoto MSc, MS Brassesco BC, LPG D'Arce MSc, SS Mello BC, LG Tone PhD, GAS Passos PhD and ET Sakamoto-Hojo PhD.

Hormone replacement therapy (HRT) after breast cancer (BC).

A Gorins, MD, M. Espie, MD, N. Bedairia, MD, F. Perret, MD, B. Tournant, MD, H Nowak, MD, E. Lucci, MD, M. Marty, MD.

Hormone replacement therapy for African American women: missed opportunities for effective intervention.

WK Nicholson, AF Brown, J Gathe, K Grumbach, AE Washington, EJ Perez-Stable

Possible role of ovarian epithelial inflammation in ovarian cancer.

RB Ness, M.D., M.P.H. C Cottreau, Ph.D.

Relevance of Helicobacter pylori virulence genes and interleukin-1 polymorphisms for the development of atrophy and gastric carcinoma

Leen-Jan van Doorn, Céu Figueiredo, José Carlos Machado, Raquel Seruca, Sónia Sousa, Ralph Carvalho, Carlos Caldas, Wim Quint, Fátima Carneiro, Manuel Sobrinho-Simões

Fluorescence endoscopy for the detection of dysplasia in ulcerative colitis using systemic or local 5-aminolevulinic acid sensitisation

E. Endlicher, G. Freunek, P. Rümmele , J. Schölmerich, R. Knüchel, H. Messmann

Lung cancer risk assessment by breath acetonitrile

FB Bodrogi, MB , PB Lirk, MB , H Raifer, BSc , A Amann, PhD , JW Rieder, MD

Low frequency of colonic dysplasias in patients with longstanding IBD-colitis

T Ochsenkuhn, MD, C Tillack, MD, H Stepp MD, R Baumgartner, MD, B Goeke, MD, M Sackmann, MD,

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas

S Andersson, MD

The risk factor of hepatitis B virus associated hepatocellular carcinoma in pediatric patients

T Sogo MD, T Fujisawa MD, A Inui MD, N Shiki MD, H Komatsu MD, I Sekine MD

Association between plasma MMP-9 activity and the outcome of breast cancer patients.

SM Ranuncolo MD, E Armanasco MD, C Cresta MD, EDBK Joffe MD PhD and LI Puricelli PhD.

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 carriers.

P Ghadirian, MP Dubé,, S Narod,

Distinct prevalence of CYP19 del3(TTTA)7 allele in premenopausal versus postmenopausal breast cancer patients

K.P. Hanson, PhD MD, E.N. Suspitsin, MD, MY Grigoriev, MD, A.V. Togo, PhD, ES Kuligina, PhD, E.V. Belogubova, PhD, K.M. Pozharisski, PhD MD, Oleg L. Chagunava, PhD MD, E.P. Sokolov, PhD, C. Theillet, PhD, L.M. Berstein, PhD MD, E.N. Imyanitov, PhD MD

Investigation of the effects of folic acid deficiency on colon carcinogenesis

GR Wasson, BSc, AP McGlynn, PhD, SR O'Reilly, BSc, VJ McKelvey-Martin, PhD, JJ Strain, PhD, DG Weir, MD, JM Scott, PhD, ScD, CS Downes, PhD and H McNulty, PhD

BRCA2 and genetic instability

VP Yu, MA, MB/BChir, PhD

Human papillomavirus prevalence, integration, and expression in head and neck cancers.

E.M. Smith , KF Summersgill, J.M. Ritchie, J.R. Anson, M.J. Lace , H.T. Hoffman, J.P. Klussmann, H.P. Dienes, T.H. Haugen , L.P. Turek

PCR-ISH application potentiates the clinical and diagnostic assessment of cervical tissue.

R. Li Vigni PhD, U.A Bianchi MD, G. Carosi MD, M. Lomini MD, S. Pecorelli MD.